In the high-stakes world of clinical trials, choosing between fragmented point solutions and a unified clinical research software can make or break your study’s success.
Meanwhile, the clinical trial industry is making enormous efforts to drive qualitative outcomes. Efficient data collection and patient engagement are more necessary than ever. This
Source: American Pharmaceutical Review Gene therapies stand at the forefront of medical breakthroughs, promising revolutionary treatment possibilities. These therapies involve manipulating or modifying genes to
Source: SCRIP CITELINE COMMERCIAL Jeeva’s founder and CEO talks to Scrip about how the firm’s clinical trial management platform does away with the need for
The need for greater patient engagement isn’t a new issue today. It has persisted for decades, and the struggle to optimize it is still a
Source: BioSupply Trends Quarterly CLINICAL TRIALS are the linchpin for bringing new medications to market, and they depend on patient participation. However, stalled patient recruitment
Source: Rare Disease and Orphan Drug Journal Abstract One of the main challenges in rare diseases is the unavailability of reliable estimates of prevalence and
Source: Dermatology Times Gender gaps, with consistent underrepresentation of females, present a substantial challenge in clinical research.(1) Achieving a balanced representation of both genders has
Source: The Company of Biologists Rare diseases affect only a few people in a given population but, collectively, they impact over 400 million people globally
Source: PRWeb Dr. Harsha Rajasimha, Founder and CEO of Jeeva Trials, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on
Jeeva Clinical Trials Inc.